Ventricular Function, Left
"Ventricular Function, Left" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
Concept/Terms
Ventricular Function, Left- Ventricular Function, Left
- Left Ventricular Function
- Function, Left Ventricular
- Functions, Left Ventricular
- Left Ventricular Functions
- Ventricular Functions, Left
Below are MeSH descriptors whose meaning is more general than "Ventricular Function, Left".
Below are MeSH descriptors whose meaning is more specific than "Ventricular Function, Left".
This graph shows the total number of publications written about "Ventricular Function, Left" by people in Harvard Catalyst Profiles by year, and whether "Ventricular Function, Left" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 16 | 21 | 37 |
1995 | 13 | 13 | 26 |
1996 | 4 | 15 | 19 |
1997 | 12 | 8 | 20 |
1998 | 7 | 24 | 31 |
1999 | 9 | 14 | 23 |
2000 | 7 | 16 | 23 |
2001 | 6 | 10 | 16 |
2002 | 9 | 15 | 24 |
2003 | 14 | 21 | 35 |
2004 | 8 | 16 | 24 |
2005 | 11 | 13 | 24 |
2006 | 11 | 15 | 26 |
2007 | 16 | 9 | 25 |
2008 | 19 | 17 | 36 |
2009 | 24 | 29 | 53 |
2010 | 22 | 27 | 49 |
2011 | 23 | 26 | 49 |
2012 | 42 | 32 | 74 |
2013 | 37 | 29 | 66 |
2014 | 48 | 23 | 71 |
2015 | 49 | 27 | 76 |
2016 | 47 | 29 | 76 |
2017 | 66 | 34 | 100 |
2018 | 58 | 40 | 98 |
2019 | 73 | 39 | 112 |
2020 | 69 | 79 | 148 |
2021 | 27 | 100 | 127 |
2022 | 22 | 125 | 147 |
2023 | 7 | 118 | 125 |
2024 | 5 | 24 | 29 |
Below are the most recent publications written about "Ventricular Function, Left" by people in Profiles.
-
Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2024 Apr 09; 83(14):1348-1350.
-
Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction. JACC Heart Fail. 2024 Apr; 12(4):628-630.
-
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. J Am Coll Cardiol. 2024 Mar 26; 83(12):1123-1132.
-
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms. Nat Commun. 2024 Mar 21; 15(1):2536.
-
Mortality in patients with normal left ventricular function requiring emergency VA-ECMO for postcardiotomy cardiogenic shock due to coronary malperfusion. PLoS One. 2024; 19(3):e0300568.
-
Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling. J Am Heart Assoc. 2024 Mar 19; 13(6):e031029.
-
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial. JAMA Cardiol. 2024 Mar 01; 9(3):283-289.
-
Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study. Glob Heart. 2024; 19(1):26.
-
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. J Am Heart Assoc. 2024 Mar 05; 13(5):e032279.
-
Right ventricular free wall and four-chamber longitudinal strain in relation to incident heart failure in the general population. Eur Heart J Cardiovasc Imaging. 2024 Feb 22; 25(3):396-403.